Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital-acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus, as well as to treat lung infections caused by Staphylococcus aureus in patients with cystic fibrosis. Motif Bio plc was incorporated in 2014 and is based in New York, New York.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone609-608-0032
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date5/1/2019 (Estimated)
OptionableNot Optionable
Motif Bio (LON:MTFB) Frequently Asked Questions
What is Motif Bio's stock symbol?
Motif Bio trades on the London Stock Exchange (LON) under the ticker symbol "MTFB."
When is Motif Bio's next earnings date?
What price target have analysts set for MTFB?
1 brokers have issued 1-year price targets for Motif Bio's stock. Their forecasts range from GBX 95 to GBX 116. On average, they expect Motif Bio's stock price to reach GBX 105.50 in the next year. This suggests a possible upside of 1,420.5% from the stock's current price. View Analyst Price Targets for Motif Bio.
What is the consensus analysts' recommendation for Motif Bio?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Motif Bio in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Motif Bio.
Has Motif Bio been receiving favorable news coverage?
Headlines about MTFB stock have trended positive this week, according to InfoTrie. The research firm ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Motif Bio earned a daily sentiment score of 2.1 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the company's share price in the near future.
Who are some of Motif Bio's key competitors?
Some companies that are related to Motif Bio include OptiBiotix Health (OPTI), 4d Pharma (DDDD), Pediapharm (PDP), Antibe Therapeutics (ATE), Actinium Pharmaceuticals (ATNM), Tiziana Life Sciences (TILS), Verona Pharma (VRP), Actinogen Medical (ACW), Helix Biopharma (HBP), Immunoprecise Antibodies (IPA), Biotron (BIT), Asterias Biotherapeutics (AST), Noxopharm (NOX), Aerpio Pharmaceuticals (ARPO) and Oncolytics Biotech (ONC).
What other stocks do shareholders of Motif Bio own?
Who are Motif Bio's key executives?
Motif Bio's management team includes the folowing people:
- Mr. Graham George Lumsden, CEO & Exec. Director (Age 59)
- Mr. Jonathan E. Gold, CFO & Exec. Director (Age 46)
- Dr. David B. Huang, Chief Medical Officer (Age 44)
- Mr. Robert Dickey IV, Advisor (Age 63)
- Liam O'Donoghue, Company Sec.
How do I buy shares of Motif Bio?
Shares of MTFB and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Motif Bio's stock price today?
One share of MTFB stock can currently be purchased for approximately GBX 6.94.
How big of a company is Motif Bio?
Motif Bio has a market capitalization of £20.64 million.
What is Motif Bio's official website?
How can I contact Motif Bio?
Motif Bio's mailing address is One Tudor Street, LONDON, EC4Y 0AH, United Kingdom. The company can be reached via phone at 609-608-0032.
MarketBeat Community Rating for Motif Bio (LON MTFB)
MarketBeat's community ratings are surveys of what our community members think about Motif Bio and other stocks. Vote "Outperform" if you believe MTFB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTFB will underperform the S&P 500 over the long term. You may vote once every thirty days.
